Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study

Clinical Genitourinary Cancer

Volumn 13, Issue 5, 2015, Pages e347-e351

  Yang, Shuman ^a   Pinney, Susan M ^a,b   Mallick, Palash ^a   Ho, Shuk Mei ^a,b   Bracken, Bruce ^a   Wu, Tianying ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b INTERNATIONAL PAPER   (United States)

Author keywords

Advanced glycation end products; Carboxymethyllysine; F2 isoprostanes; Fluorescent oxidation products; Prostate cancer

Indexed keywords

6 N CARBOXYMETHYLLYSINE; BIOLOGICAL MARKER; GLUCOSE; ISOPROSTANE DERIVATIVE; PLASMA FLUORESCENT OXIDATION PRODUCT; UNCLASSIFIED DRUG; LYSINE; N(6)-CARBOXYMETHYLLYSINE;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; BODY MASS; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILY HISTORY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MALE; MEDICAL HISTORY; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; SMOKING; URINALYSIS; ANALOGS AND DERIVATIVES; BLOOD; METABOLISM; PROSTATE TUMOR; REGRESSION ANALYSIS; URINE;

AGED; BIOMARKERS; CASE-CONTROL STUDIES; HUMANS; LYSINE; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 84941600928     PISSN: 15587673     EISSN: 19380682     Source Type: Journal    
DOI: 10.1016/j.clgc.2015.04.004     Document Type: Article

References (39)

1. R. Siegel, J.M. Ma, Z.H. Zou, and A. Jemal Cancer statistics, 2014 CA Cancer J Clin 64 2014 9 29
2. Cancer Facts and Figures 2014. American Cancer Society; 2014.
3. V. Sosa, T. Moline, R. Somoza, R. Paciucci, H. Kondoh, and M.E. LLeonart Oxidative stress and cancer: an overview Ageing Res Rev 12 2013 376 390
4. L. Khandrika, B. Kumar, S. Koul, P. Maroni, and H.K. Koul Role of oxidative stress in prostate cancer Cancer Lett 282 2009 125 136
5. A. Minelli, I. Bellezza, C. Conte, and Z. Culig Oxidative stress-related aging: a role for prostate cancer? Biochim Biophys Acta 1795 2009 83 91
6. G. Gupta-Elera, A.R. Garrett, R.A. Robison, and K.L. O'Neill The role of oxidative stress in prostate cancer Eur J Cancer Prev 21 2012 155 162
7. N.E. Fleshner, and L.H. Klotz Diet, androgens, oxidative stress and prostate cancer susceptibility Cancer Metastasis Rev 17 1998 325 330
8. E. Lonn, J. Bosch, S. Yusuf, and et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial JAMA 293 2005 1338 1347
9. V.A. Kirsh, R.B. Hayes, S.T. Mayne, and et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk J Natl Cancer Inst 98 2006 245 254
10. D.A. Barocas, S. Motley, M.S. Cookson, and et al. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer J Urol 185 2011 2102 2107
11. J.K. Gill, A.A. Franke, J. Steven Morris, and et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort Cancer Causes Control 20 2009 1161 1171
12. Z. Arsova-Sarafinovska, A. Eken, N. Matevska, and et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer Clin Biochem 42 2009 1228 1235
13. M.K. Jensen, Y. Wang, E.B. Rimm, M.K. Townsend, W. Willett, and T. Wu Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women J Am Heart Assoc 2 2013 e000195
14. R.T. Fortner, S.S. Tworoger, T. Wu, and A.H. Eliassen Plasma fluorescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study Breast Cancer Res Treat 141 2013 307 316
15. C.M. Rebholz, T. Wu, L.L. Hamm, and et al. The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study Am J Nephrol 36 2012 297 304
16. T. Wu, N. Rifai, W.C. Willett, and E.B. Rimm Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men Am J Epidemiol 166 2007 544 551
17. E.N. Frankel Lipid Oxidation 2nd ed 2005 The Oily Press LTD Dundee, Scotland
18. W.A. Prayor Free Radicals in Biology 1980 Academic Press New York
19. J.H. Liang, and C.C. Lin Fluorescence kinetics of soybean flour oxidation J Am Oil Chem Soc 77 2000 709 713
20. A. Goldin, J.A. Beckman, A.M. Schmidt, and M.A. Creager Advanced glycation end products: sparking the development of diabetic vascular injury Circulation 114 2006 597 605
21. M.J. Noordzij, J.D. Lefrandt, and A.J. Smit Advanced glycation end products in renal failure: an overview J Ren Care 34 2008 207 212
22. H. Ishiguro, N. Nakaigawa, Y. Miyoshi, K. Fujinami, Y. Kubota, and H. Uemura Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development Prostate 64 2005 92 100
23. R. Wones, S.M. Pinney, J.M. Buckholz, C. Deck-Tebbe, R. Freyberg, and A. Pesce Medical monitoring: a beneficial remedy for residents living near an environmental hazard site J Occup Environ Med 51 2009 1374 1383
24. Killough GG, Case MJ, Meyer KR, et al. The Fernald Dosimetry Reconstruction Project: Task 6: Radiation Doses and Risk to Residents From FMPC Operations From 1951-1988. Volume 1. Neeses, SC: Center for Disease Control and Prevention; 1998.
25. J.D. Morrow, W.E. Zackert, J.P. Yang, and et al. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay Anal Biochem 269 1999 326 331
26. T.Y. Wu, W.C. Willett, N. Rifai, and E.B. Rimm Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies Am J Epidemiol 166 2007 552 560
27. E.N. Farankel Lipid Oxidation 1998 The Oily Press Dundee
28. G. De Pergola, and F. Silvestris Obesity as a major risk factor for cancer J Obes 2013 2013 291546
29. R. Inagi Inhibitors of advanced glycation and endoplasmic reticulum stress Methods Enzymol 491 2011 361 380
30. L.J. Mandarino, A. Consoli, A. Jain, and D.E. Kelley Differential regulation of intracellular glucose metabolism by glucose and insulin in human muscle Am J Physiol 265 1993 E898 E905
31. E. Jequier Effect of lipid oxidation on glucose utilization in humans Am J Clin Nutr 67 1998 527S 530S
32. D.E. Kelley Skeletal muscle fat oxidation: timing and flexibility are everything J Clin Invest 115 2005 1699 1702
33. D. II'yasova, I. Spasojevic, K. Base, and et al. Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes Diabetes Care 35 2012 173 174
34. A. Aydin, Z. Arsova-Sarafinovska, A. Sayal, and et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia Clin Biochem 39 2006 176 179
35. O. Yossepowitch, I. Pinchuk, U. Gur, A. Neumann, D. Lichtenberg, and J. Baniel Advanced but not localized prostate cancer is associated with increased oxidative stress J Urol 178 2007 1238 1244
36. C. Cheng, K. Tsuneyama, R. Kominami, and et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs Mod Pathol 18 2005 1385 1396
37. M. Takada, T. Koizumi, H. Toyama, Y. Suzuki, and Y. Kuroda Differential expression of RAGE in human pancreatic carcinoma cells Hepatogastroenterology 48 2001 1577 1578
38. A. Taguchi, D.C. Blood, G. del Toro, and et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases Nature 405 2000 354 360
39. H. Kuniyasu, N. Oue, A. Wakikawa, and et al. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer J Pathol 196 2002 163 170